DCF — MEDICAL CITY DALLAS
Enterprise Value: $844.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$844.5M
Enterprise Value
$215.0M
PV of Cash Flows
$629.6M
PV of Terminal Value
$1.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.4B | $116.0M | 8.0% | $37.8M | $34.3M |
| Year 2 | $1.4B | $133.6M | 9.0% | $49.4M | $40.9M |
| Year 3 | $1.4B | $152.0M | 10.0% | $61.8M | $46.4M |
| Year 4 | $1.5B | $164.1M | 11.0% | $69.2M | $47.3M |
| Year 5 | $1.5B | $172.8M | 11.0% | $74.2M | $46.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $844.5M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.3B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999963777171
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5